News & Events
Dec 20, 2018
CathWorks FFRangio™ System Receives U.S. FDA Clearance.
CathWorks announced today that its FFRangio™ System received United States Food & Drug Administration (FDA) 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive FFR wire in a blinded comparative study, FAST-FFR.
Sep 24, 2018
CathWorks FFRangio™ Trial Meets Primary Enpoint and Exceeds Performance Goals
The journal Circulation published results from the CathWorks FFRangio™ FAST-FFR clinical trial in an article titled Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.
Sep 24, 2018 – San Diego, CA
Lunch Presentation Theater Program
FFRangio for PCI Guidance:
A Clinical Review